Hernia, Ventral
52
5
8
28
Key Insights
Highlights
Success Rate
97% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 40/100
1.9%
1 terminated out of 52 trials
96.6%
+10.0% vs benchmark
12%
6 trials in Phase 3/4
25%
7 of 28 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 28 completed trials
Clinical Trials (52)
GORE® ENFORM Biomaterial Product Study
Recover@Home Postoperative Follow-up Study
Transorb™ Self-Gripping Resorbable Mesh in High-risk Subjects Undergoing Open Repair of Ventral Hernia
Ventral or Inguinal Hernia, Robotically Repaired With OviTex Mesh
Prospective Randomized Trial of Moderate vs Deep Neuromuscular Blockade During Laparoscopic Ventral Hernia Repair
A Study to Understand the Utility of the Force Feedback Instruments in Robotic Procedures Using da Vinci 5 Robot
Compliance-Guided Abdominal Wall Closure Strategy in Large Ventral Hernia Repair
Assessment of GORE® SYNECOR Biomaterial in Focused Patient Populations and Long-Term Application
Preoptimisation in Ventral Hernia Surgery
Abdominal Wall Tension in Patients Undergoing Ventral Hernia Repair Without Component Separation
The Impact of Sugammadex on Ileus After Abdominal Wall Reconstruction
RCT of Two Noncrosslinked Porcine Acellular Dermal Matrices in Ab Wall Reconstruction
T-GENVIH-003 LTFU (Long Term Follow Up) Study
Quadratus Lumborum Versus Placebo in Open Ventral Hernia Repair
Optimization of Surgical Treatment of Patients With Incisional Ventral Hernias
Short Term Outcomes of Heavy-weight Versus Medium-weight Synthetic Mesh
Endoscopic eTEP Versus Open Rives-Stoppa
Pain and Readmission After Lap IPOM vs. Robotic Ventral Hernia Repair
Patient Centered Outcomes Study
Endoscopic Mini/Less Open Sublay(EMILOS) Repair